Ceevra 3D Surgical Imaging Platform
AI-driven 3D surgical planning models from CT/MRI scans
Company profile
Company profile
Ceevra is a San Francisco-based medical software company that transforms surgical planning through AI-driven 3D imaging technology. Using FDA-cleared machine learning and computer vision algorithms, Ceevra generates detailed, interactive 3D digital models from CT and MRI scans that surgeons can view on phones, tablets, laptops, and surgical robotic displays. The platform supports numerous surgical specialties including thoracic, urologic, general, hepatopancreatobiliary (HPB), and gynecologic surgery, and is used in open, laparoscopic, and robotic procedures. Ceevra's models are generated entirely by the company using AI-driven software and in-house imaging technologists, requiring no effort from hospital personnel. The 3D models routinely and significantly impact how surgeons approach their operations, with two randomized clinical trials demonstrating substantial patient outcomes improvements. For robotic partial nephrectomy and robotic prostatectomy procedures, studies published in JAMA Network Open showed significant improvements in cancer control, erectile function, and rates of adjuvant therapy. The platform is purchased as an annual software subscription with various tiers based on anticipated volume, and can combine multiple surgical specialties and hospitals from the same health system. Ceevra's comprehensive coverage enables hospitals to offer 3D imaging to a broad spectrum of surgeons and patients, improving both surgical planning and patient counseling experiences.
Company description Ceevra official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Hybrid deployment with recorded integration context.
Recorded integration context: PACS.
Company milestones
FDA 510(k) clearance for AI-powered surgical planning 3D software (May 2023), EU MDR certification (June 2024), JAMA Network Open publication on prostatectomy outcomes (September 2024), AATS presentation on segmentectomy outcomes (September 2025)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-driven 3D surgical planning models from CT/MRI scans
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
NCT03334344 · Sponsor · COMPLETED
Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNCNCT03870269 · Sponsor · COMPLETED
Using Virtual Reality (VR) Models for Robotic ProstatectomyNCT03943368 · Sponsor · COMPLETED
Regulatory
K243933 · 510k · Mar 4, 2025
Ceevra Reveal 3+K233568 · 510k · Dec 5, 2023
Ceevra Reveal 3K222676 · 510k · Apr 25, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
robotic prostatectomy using Ceevra 3D models vs MRI alone
robotic prostatectomy procedures
robotic prostatectomy procedures
robotic prostatectomy procedures
across multiple surgical specialties
Surgical planning for robotic prostatectomy using Ceevra 3D models
Trifecta Outcomes rates nearly 5x higher than operations using only MRI; significantly improved cancer control, erectile function, and rates of adjuvant therapy
Surgical innovation and advances using Ceevra 3D models
Innovation and surgical advances for patients
Surgical planning for robotic partial nephrectomy using 3D virtual reality models
Substantial patient outcomes improvements demonstrated in randomized clinical trial
Gynecological surgery myomectomy procedures with 3D imaging
Benefits practice and patient care
Thoracic oncology surgical planning for segmentectomy and sublobar resection procedures
Described as 'indispensable to surgical planning' and 'huge advantage'
Thoracic surgery planning - helps surgeons decide surgical approach and identify anatomical variations before entering OR
Saves time in OR by enabling pre-operative surgical approach planning
Thoracic surgery segmentectomy procedures using Ceevra 3D imaging
Significantly impacts surgical approach decisions
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Ceevra's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.